Health Trials

Low-grade Cervical Intraepithelial Neoplasia

1

Review clinical trials related to Low-grade Cervical Intraepithelial Neoplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)

MODUCIN-1 (MODUcare for CIN1) is a prospective, single center, open-label, randomized trial that its purpose is to compare MODUCARE versus Wait-and-See Approach for the regression rate of histologically proven low-grade Cervical Intraepithelial Neoplasia (CIN1).

Participants needed: 182
Trial details
Age: 18-85Biological sex: FemaleType: InterventionalSponsor: Aristotle University Of ThessalonikiUpdated: Feb 5, 2026
Eligibility criteria

Histologically proven CIN1 [+4]

Pregnancy [+6]

Read more